Acadia Pharmaceuticals Inc (ACAD)
Total Liabilities
$436.29M
Quarterly · Period ending: · USD
ACAD Total Liabilities
Latest reported$436.29Mperiod ending
Latest reported$436.29Mperiod ending
ACAD Quarterly Total Liabilities ($84.36M → $436.29M)
Quarterly total liabilities
High-resolution chart · PNG
ACAD total liabilities history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Total Liabilities (USD) |
|---|---|
| 436,291,000 | |
| 357,164,000 | |
| 336,805,000 | |
| 413,499,000 | |
| 403,173,000 | |
| 367,127,000 | |
| 454,963,000 | |
| 399,688,000 | |
| 397,399,000 | |
| 391,059,000 | |
| 317,201,000 | |
| 270,366,000 | |
| 246,976,000 | |
| 281,047,000 | |
| 187,399,000 | |
| 176,805,000 | |
| 177,918,000 | |
| 179,454,000 | |
| 159,228,000 | |
| 150,718,000 | |
| 159,591,000 | |
| 173,567,000 | |
| 155,607,000 | |
| 140,797,000 | |
| 96,636,000 | |
| 109,068,000 | |
| 84,048,000 | |
| 76,297,000 | |
| 71,969,000 | |
| 82,749,000 | |
| 61,123,000 | |
| 43,016,000 | |
| 50,240,000 | |
| 46,871,000 | |
| 49,221,000 | |
| 36,388,000 | |
| 41,175,000 | |
| 45,489,000 | |
| 42,742,000 | |
| 39,326,000 | |
| 29,219,000 | |
| 21,339,000 | |
| 22,134,000 | |
| 17,974,000 | |
| 19,718,000 | |
| 16,869,000 | |
| 15,969,000 | |
| 11,274,000 | |
| 9,357,000 | |
| 8,046,000 | |
| 6,987,000 | |
| 18,531,000 | |
| 25,434,000 | |
| 23,353,000 | |
| 23,606,000 | |
| 6,086,000 | |
| 9,166,000 | |
| 8,934,000 | |
| 8,752,000 | |
| 8,878,000 | |
| 8,488,000 | |
| 8,779,000 | |
| 8,706,000 | |
| 35,924,000 | |
| 36,010,000 | |
| 36,175,000 | |
| 37,566,000 | |
| 39,508,000 | |
| 43,650,000 | |
| 11,985,000 | |
| 11,685,000 | |
| 11,961,000 | |
| 14,876,000 | |
| 14,658,000 | |
| 20,650,000 | |
| 18,612,000 | |
| 15,951,000 | |
| 18,953,000 | |
| 22,385,000 | |
| 22,513,000 | |
| 27,022,000 | |
| 23,659,000 | |
| 23,134,700 | |
| 21,073,800 | |
| 12,481,000 | |
| 13,553,700 | |
| 9,684,600 | |
| 10,390,300 | |
| 10,511,700 | |
| 85,831,600 | |
| 84,364,000 |